Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $1,527,322 |
Sells | 25 | $746,884 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Feb 2025 16:21 | PASG | Passage BIO Inc | BORTHWICK KATHLEEN | CFO | 11 Feb 2025 | Sale | 3,183 | 0.5296 | 1,686 | D |
14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 10 Jan 2025 | Sale | 126,209 | 0.66 | 83,298 | I |
14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 13 Jan 2025 | Sale | 17,986 | 0.64 | 11,511 | I |
14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 14 Jan 2025 | Sale | 79,024 | 0.6 | 47,414 | I |
08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 06 Jan 2025 | Sale | 19,481 | 0.77 | 15,000 | I |
08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 07 Jan 2025 | Sale | 52,536 | 0.71 | 37,301 | I |
08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 08 Jan 2025 | Sale | 75,007 | 0.68 | 51,005 | I |
31 Dec 2024 16:05 | PASG | Passage BIO Inc | LYNX1 CAPITAL MANAGEMENT LP | 10% | 27 Dec 2024 | Purchase | 373,645 | 0.6451 | 241,038 | I |
26 Dec 2024 16:34 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 20 Dec 2024 | Sale | 230,321 | 0.6 | 138,193 | I |
11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 09 Dec 2024 | Sale | 54,181 | 0.84 | 45,512 | I |
11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 10 Dec 2024 | Sale | 8,015 | 0.8 | 6,412 | I |
11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 11 Dec 2024 | Sale | 80 | 0.8 | 64 | I |
06 Dec 2024 19:07 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 04 Dec 2024 | Sale | 76,200 | 0.79 | 60,198 | I |
06 Dec 2024 19:07 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 06 Dec 2024 | Sale | 20,903 | 0.82 | 17,140 | I |
27 Nov 2024 18:11 | PASG | Passage BIO Inc | LYNX1 CAPITAL MANAGEMENT LP | 10% | 25 Nov 2024 | Purchase | 259,998 | 0.5641 | 146,665 | I |
27 Nov 2024 18:11 | PASG | Passage BIO Inc | LYNX1 CAPITAL MANAGEMENT LP | 10% | 26 Nov 2024 | Purchase | 167,055 | 0.7075 | 118,191 | I |
27 Nov 2024 18:11 | PASG | Passage BIO Inc | LYNX1 CAPITAL MANAGEMENT LP | 10% | 27 Nov 2024 | Purchase | 29,300 | 0.6711 | 19,663 | I |
23 Sep 2024 16:51 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 19 Sep 2024 | Sale | 39,300 | 0.71 | 27,903 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 18 Sep 2024 | Sale | 25,631 | 0.73 | 18,711 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 17 Sep 2024 | Sale | 111,400 | 0.73 | 81,322 | I |
18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 16 Sep 2024 | Sale | 63,100 | 0.74 | 46,694 | I |
13 Feb 2024 19:36 | PASG | Passage BIO Inc | BORTHWICK KATHLEEN | SVP, INTERIM CFO | 13 Feb 2024 | Sale | 1,470 | 0.97 | 1,426 | D |
13 Feb 2024 19:34 | PASG | Passage BIO Inc | FORMAN MARK S | CHIEF MEDICAL OFFICER | 13 Feb 2024 | Sale | 1,638 | 0.97 | 1,589 | D |
03 Jan 2024 16:21 | PASG | Passage BIO Inc | FORMAN MARK S | Chief Medical Officer | 02 Jan 2024 | Sale | 15,813 | 0.91 | 14,390 | D |
03 Jan 2024 16:20 | PASG | Passage BIO Inc | BORTHWICK KATHLEEN | SVP, Interim CFO | 02 Jan 2024 | Sale | 10,672 | 0.91 | 9,712 | D |
03 Jan 2024 16:19 | PASG | Passage BIO Inc | CALE EDGAR B. | GC & Corporate Secretary | 02 Jan 2024 | Sale | 15,813 | 0.91 | 14,390 | D |
01 Aug 2023 16:36 | PASG | Passage BIO Inc | KING SIMONA | Chief Financial Officer | 28 Jul 2023 | Sale | 11,453 | 0.88 | 10,079 | D |
29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2023 | Purchase | 575,195 | 0.84 | 483,164 | I |
29 Jun 2023 16:42 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 27 Jun 2023 | Purchase | 617,382 | 0.84 | 518,601 | I |
20 Jun 2023 16:10 | PASG | Passage BIO Inc | FOTOPOULOS ALEXANDROS | Chief Technical Officer | 16 Jun 2023 | Sale | 4,052 | 0.9325 | 3,778 | D |
20 Apr 2023 16:28 | PASG | Passage BIO Inc | KING SIMONA | Chief Financial Officer | 18 Apr 2023 | Sale | 2,053 | 1.05 | 2,156 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)